Journal Article
. 2020 Jan; 12(4):1385-1390.

Osteopontin expression is associated with progression and adverse prognosis in patients with resectable gastrointestinal stromal tumor

Jinhai Wang 1 Xiaobin Cheng 1 Sen Lu 1 Weina Fan 2 
Affiliations
  • PMID: 31933953
  •     27 References

Abstract

Objectives: Osteopontin (OPN) is reported to be particularly associated with the progression of several human malignancies. This study was designed to examine the clinicopathologic significance of OPN in gastrointestinal stromal tumor (GISTs).

Methods: The level of OPN expression in a large cohort of resectable GISTs was evaluated with immunohistochemistry. Its correlation with the clinicopathologic parameters of patients with resectable GISTs was analyzed. A survival analysis was performed to evaluate the prognostic significance of OPN expression using the Kaplan-Meier method.

Results: In 108 patients with resectable GISTs, the most high-risk GISTs had a strong level of OPN expression. Strong OPN expression was also significantly associated with tumor size, mitosis, and recurrence, but not gender and age. Patients with weak OPN expression had a relatively longer disease-free survival compared to patients with strong OPN expression.

Conclusions: OPN expression is a putative marker for tumor progression and an adverse prognosis in GISTs.

Keywords: Osteopontin; gastrointestinal stromal tumors; immunohistochemistry; prognosis.

Other Links

Free PMC article 
Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
T M Tilli, L C Thuler, +6 authors, E R Gimba.
Exp Mol Pathol, 2011 Oct 04; 92(1). PMID: 21963599
Imatinib: a selective tyrosine kinase inhibitor.
P W Manley, S W Cowan-Jacob, +5 authors, J Zimmermann.
Eur J Cancer, 2003 Jan 17; 38 Suppl 5. PMID: 12528769
Review.
DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Markku Miettinen, Zeng-Feng Wang, Jerzy Lasota.
Am J Surg Pathol, 2009 Jul 17; 33(9). PMID: 19606013
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response.
J W Thoms, A Dal Pra, +9 authors, R G Bristow.
Br J Cancer, 2012 Aug 09; 107(5). PMID: 22871886    Free PMC article.
Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma.
Amy L Collins, Jonathan Rock, +2 authors, Mark Bloomston.
Ann Surg Oncol, 2012 Mar 31; 19(8). PMID: 22461132    Free PMC article.
Regulatory role of osteopontin in malignant transformation of endometrial cancer.
Sabarish Ramachandran, Kun-Young Kwon, +7 authors, Chi-Heum Cho.
Mol Biol Rep, 2012 Dec 28; 40(5). PMID: 23269624
Review article: the biology, diagnosis and management of gastrointestinal stromal tumours.
N Iorio, R A Sawaya, F K Friedenberg.
Aliment Pharmacol Ther, 2014 Apr 23; 39(12). PMID: 24749828
Review.
Diagnosis of gastrointestinal stromal tumors: A consensus approach.
Christopher D M Fletcher, Jules J Berman, +10 authors, Sharon W Weiss.
Hum Pathol, 2002 Jul 03; 33(5). PMID: 12094370
Highly Cited. Review.
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.
D T Denhardt, M Noda, +2 authors, J S Berman.
J Clin Invest, 2001 May 09; 107(9). PMID: 11342566    Free PMC article.
Highly Cited. Review.
Osteopontin.
J Sodek, B Ganss, M D McKee.
Crit Rev Oral Biol Med, 2000 Oct 06; 11(3). PMID: 11021631
Highly Cited. Review.
Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Markku Miettinen, Jerzy Lasota.
Pol J Pathol, 2003 Jun 24; 54(1). PMID: 12817876
Review.
Centromere protein F and survivin are associated with high risk and a poor prognosis in colorectal gastrointestinal stromal tumours.
Wen-Bin Chen, Xiao-Bin Cheng, +4 authors, Ru-Shan Fei.
J Clin Pathol, 2011 May 27; 64(9). PMID: 21613637
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
Heikki Joensuu, Mikael Eriksson, +20 authors, Peter Reichardt.
JAMA, 2012 Mar 29; 307(12). PMID: 22453568
Highly Cited.
Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.
A O'Regan, J S Berman.
Int J Exp Pathol, 2001 Apr 12; 81(6). PMID: 11298186    Free PMC article.
Review.
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
Ane Kongsgaard Rud, Kjetil Boye, +7 authors, Gunhild M Mælandsmo.
BMC Cancer, 2013 Nov 13; 13. PMID: 24215488    Free PMC article.
Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
Jianjin Huang, Chi Pan, +2 authors, Ling Ding.
PLoS One, 2012 Nov 01; 7(10). PMID: 23112867    Free PMC article.
Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.
D J Mole, C O'Neill, +6 authors, F C Campbell.
Br J Cancer, 2011 Feb 24; 104(6). PMID: 21343932    Free PMC article.
Serum level of osteopontin as a prognostic factor in patients who underwent surgical resection for non-small-cell lung cancer.
Masaru Takenaka, Takeshi Hanagiri, +10 authors, Fumihiro Tanaka.
Clin Lung Cancer, 2012 Nov 06; 14(3). PMID: 23122494
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Christopher L Corless, Karla V Ballman, +12 authors, Ronald P DeMatteo.
J Clin Oncol, 2014 Mar 19; 32(15). PMID: 24638003    Free PMC article.
Highly Cited.
Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma.
Katherine E Poruk, Matthew A Firpo, +4 authors, Sean J Mulvihill.
Pancreas, 2013 Feb 15; 42(2). PMID: 23407481    Free PMC article.
Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era.
Peter C Wu, Alex Langerman, +3 authors, Mitchell C Posner.
Surgery, 2003 Nov 08; 134(4). PMID: 14605627
Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.
Seiichi Hirota, Akiko Ohashi, +4 authors, Yukihiko Kitamura.
Gastroenterology, 2003 Sep 02; 125(3). PMID: 12949711
Highly Cited.
Gastrointestinal stromal tumours: origin and molecular oncology.
Christopher L Corless, Christine M Barnett, Michael C Heinrich.
Nat Rev Cancer, 2011 Nov 18; 11(12). PMID: 22089421
Highly Cited. Review.
Gastrointestinal stromal tumors: past, present, and future.
Yukihiko Kitamura.
J Gastroenterol, 2008 Jul 24; 43(7). PMID: 18648736
Review.
Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.
Bing-Sheng Sun, Yue Li, +2 authors, Chang-Li Wang.
Ann Thorac Surg, 2013 Oct 08; 96(6). PMID: 24094519
Current management of gastrointestinal stromal tumors: Surgery, current biomarkers, mutations, and therapy.
Nakul Valsangkar, Amikar Sehdev, +3 authors, Leonidas G Koniaris.
Surgery, 2015 Aug 06; 158(5). PMID: 26243346
Review.
Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
Biao Deng, Xiao-Fei Zhang, +5 authors, Lun-Xiu Qin.
Oncol Rep, 2013 Sep 26; 30(6). PMID: 24065086